Abilify 2 mg Tablets (Aripiprazole)

Adult dose

Schizophrenia: The recommended initial dose is 10 mg or 15 mg once daily, regardless of meals. The dosage can be adjusted within the range of 10-30 mg once daily, and should not be increased before reaching steady state within 2 weeks. Maintenance therapy: A daily dose of 15 mg for patients stabilized for over 3 months. Bipolar disorder treatment: Initiated with 15 mg once daily as monotherapy or adjunctive therapy, increased to 30 mg once daily based on clinical response

Child dose

Schizophrenia in adolescents (13-17 years): the recommended dose is 10 mg once daily, starting with 2 mg, increasing to 5 mg after 2 days, then to 10 mg after another 2 days. Bipolar disorder in children (1

This medication may increase the risk of suicidal thoughts or behaviors in children, adolescents, and young adults with depression or psychiatric disorders, so physicians should carefully assess its use. After starting treatment, the patient's condition should be closely monitored, and family members or guardians should also observe for unusual behaviors or signs of suicide risk. This medication is not approved for the treatment of pediatric depression. Additionally, it can cause a serious side effect called Neuroleptic Malignant Syndrome, which can be life-threatening, so immediate treatment is required if symptoms such as high fever, muscle rigidity, or altered consciousness appear. Long-term use may lead to the development of potentially irreversible tardive dyskinesia, and if symptoms arise, discontinuation of the medication should be considered. Elderly patients with dementia may be at an increased risk of cerebrovascular accidents such as stroke and increased mortality, so this medication is not recommended for patients with dementia-related psychiatric disorders. It may affect blood sugar control, so diabetic patients should regularly monitor their blood sugar levels. This medication may cause orthostatic hypotension, so patients with unstable blood pressure should use it with caution. Caution is also warranted in patients with a history of seizures. Drowsiness or cognitive impairment may occur, so care should be taken when driving or operating hazardous machinery. Patients with swallowing difficulties are at risk for aspiration pneumonia, so caution is necessary. This medication should not be given to those with hypersensitivity or specific genetic lactose metabolism anomalies. Various side effects such as nausea, vomiting, headache, dizziness, insomnia, anxiety, drowsiness, weight gain, etc., may occur, so if any abnormal symptoms arise, consulting a doctor is necessary. Particularly during the initial treatment period or when adjusting doses, side effects and suicidal risk should be closely monitored. It is recommended to start at the minimum effective dose and use it for the least amount of time necessary.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with fever, blisters, skin peeling, pain in oral/ocular mucosa, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough+fever, yellowing of skin or eyes (jaundice), extreme dizziness and extreme headache, thunderclap headache, seizures, altered consciousness, visual disturbances, paralysis, urination changes

Mild side effects

• Nausea
• vomiting
• constipation
• headache
• dizziness
• akathisia
• anxiety
• insomnia
• restlessness
• drowsiness

This medication should be stored in a tightly closed container to avoid exposure to air and moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees at room temperature.

Appearance

Green oval tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 200 tablets/bottle, Bottle - 100 tablets/bottle